5Austin HA Ⅲ,Muenz LR,Joyce KM,et al.Diffuse proliferative lupus nephritis identification of specific pathologic features affecting renal outcome.Kidney Int,1984,25:689-695.
6Boumpas DT,Austin HA,Vaughn EM,et al.Controlled trail of pulse methylprednisolone versus two regiments of pulse cyclophosphamide in severe lupus.N Eng1 J Med,1992,326:1373-1379.
7Lewis EJ,Hunsicker LG,Lan S-P,et al.A controlled trial of plasmapheresis in servere lupus nephritis.N Engl J Med,1992,326:1373-1379.
1Hanly J G, Fish J D, Sherwood G, et al. Clinical course of cognitive dysfunction in systemic lupus erythematosus [J]. Journal of Rheumatology, 1994, 21 : 1825 - 1831.
2Sutcliffe N. Clarke A E, Levinton C, et al. Associates of health status in patients with systemic lupus erythematosus [J]. Journal of Rheumatology, 1999, 26 : 2352 - 2356.
3Gladman D D, Urowitz W B, Ong A, et al, Lack of correlation among the 3 outcomes describing SLE:disease activity, damage and quality of life[J]. Clinical and Experimental Rheumalology, 1996,14 : 305 - 308.
